BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05231122-completion@plaintrial.com
DTSTAMP:20261027T062609Z
DTSTART;VALUE=DATE:20261230
SUMMARY:Pembrolizumab Combined With Bevacizumab With or Without Agonist Ant
 i-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cance
 r — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05231122
URL:https://plaintrial.com/trial/NCT05231122
END:VEVENT
END:VCALENDAR